or Try an Advanced Search...

    Technical Analysis for PHGE - BiomX Inc.

    Grade Last Price % Change Price Change
    C 0.34 -1.39% 0.00
    PHGE closed down 1.39 percent on Friday, May 24, 2024, on 32 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical PHGE trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    50 DMA Resistance Bearish -1.39%
    Wide Bands Range Expansion -1.39%
    20 DMA Resistance Bearish -4.76%
    Fell Below 50 DMA Bearish -4.76%
    Older End-of-Day Signals for PHGE ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 4 days ago
    50 DMA Support 4 days ago
    10 DMA Support 4 days ago
    50 DMA Resistance 4 days ago
    10 DMA Resistance 4 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PHGE Chart by TradingView
    Basic chart:

    Profile

    BiomX Inc., a clinical-stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from dysbiosis of the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases, primary sclerosing cholangitis, and cancer. The company is based in Ness Ziona, Israel.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Medicine Cancer Clinical Medicine Disease Autoimmune Disease Inflammatory Bowel Disease Chronic Disease Hepatology Digestive System Primary Sclerosing Cholangitis Bacteriophage

    Is PHGE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 21 BiomX (PHGE) Q1 2024 Earnings Call Transcript
    May 21 BiomX GAAP EPS of -$0.28
    May 21 BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates
    May 15 BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
    Apr 29 BiomX files to sell 120.15M warrants for holders
    Apr 23 BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
    Apr 18 BiomX Announces the Appointment of Susan Blum to its Board of Directors
    Apr 5 Here's Why BiomX (PHGE) Is a Great 'Buy the Bottom' Stock Now
    Apr 4 BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
    Apr 3 BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript
    See more PHGE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.855
    52 Week Low 0.1866
    Average Volume 255,517
    200-Day Moving Average 0.33
    50-Day Moving Average 0.36
    20-Day Moving Average 0.37
    10-Day Moving Average 0.34
    Average True Range 0.05
    RSI (14) 46.52
    ADX 20.96
    +DI 19.47
    -DI 13.20
    Chandelier Exit (Long, 3 ATRs) 0.36
    Chandelier Exit (Short, 3 ATRs) 0.44
    Upper Bollinger Bands 0.45
    Lower Bollinger Band 0.30
    Percent B (%b) 0.29
    BandWidth 40.94
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram -0.0033
    Fundamentals Value
    Market Cap 15.63 Million
    Num Shares 46 Million
    EPS -0.63
    Price-to-Earnings (P/E) Ratio -0.54
    Price-to-Sales 0.00
    Price-to-Book 1.27
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.37
    Resistance 3 (R3) 0.37 0.37 0.37
    Resistance 2 (R2) 0.37 0.36 0.36 0.36
    Resistance 1 (R1) 0.35 0.35 0.35 0.35 0.36
    Pivot Point 0.35 0.35 0.34 0.34 0.35
    Support 1 (S1) 0.33 0.34 0.33 0.33 0.32
    Support 2 (S2) 0.33 0.33 0.32 0.32
    Support 3 (S3) 0.31 0.33 0.31
    Support 4 (S4) 0.31